-
Clinical Medicine (London, England) Jan 2022
Topics: Education, Medical, Continuing; Humans; Self-Assessment; Surveys and Questionnaires; Tropical Medicine
PubMed: 35078792
DOI: 10.7861/clinmed.SAQ.22.1 -
Revista Da Sociedade Brasileira de... 2020
Topics: Brazil; History, 19th Century; History, 20th Century; Humans; Male; Public Health; Tropical Medicine
PubMed: 32844902
DOI: 10.1590/0037-8682-0313b-2020 -
The Lancet. Global Health Nov 2021Talaromycosis (penicilliosis) is an invasive mycosis that is endemic in tropical and subtropical Asia. Talaromycosis primarily affects individuals with advanced HIV... (Review)
Review
Talaromycosis (penicilliosis) is an invasive mycosis that is endemic in tropical and subtropical Asia. Talaromycosis primarily affects individuals with advanced HIV disease and other immunosuppressive conditions, and the disease disproportionally affects people in low-income and middle-income countries, particularly agricultural workers in rural areas during their most economically productive years. Approximately 17 300 talaromycosis cases and 4900 associated deaths occur annually. Talaromycosis is highly associated with the tropical monsoon season, when flooding and cyclones can exacerbate the poverty-inducing potential of the disease. Talaromycosis can present as localised or disseminated disease, the latter causing cutaneous lesions that are disfiguring and stigmatising. Despite up to a third of diagnosed cases resulting in death, talaromycosis has received little attention and investment from regional and global funders, policy makers, researchers, and industry. Diagnostic and treatment modalities remain extremely insufficient, however control of talaromycosis is feasible with known public health strategies. This Viewpoint is a global call for talaromycosis to be recognised as a neglected tropical disease to alleviate its impact on susceptible populations.
Topics: Asia; Humans; Mycoses; Neglected Diseases; Public Health; Tropical Medicine
PubMed: 34678201
DOI: 10.1016/S2214-109X(21)00350-8 -
Medecine Et Sante Tropicales 2013
Topics: Africa; Developing Countries; International Cooperation; Tropical Medicine
PubMed: 24480598
DOI: 10.1684/mst.2014.0282 -
PLoS Neglected Tropical Diseases Nov 2018Mobile applications (apps) can bring health research and its potential downstream benefits closer to underserved populations. Drawing on experience developing an app for... (Review)
Review
Mobile applications (apps) can bring health research and its potential downstream benefits closer to underserved populations. Drawing on experience developing an app for detecting and referring cases of cutaneous leishmaniasis in Colombia, called Guaral/app, we review key steps in creating such mobile health (mHealth) tools. These require consideration of the sociotechnical context using methods such as systems analysis and human-centered design (HCD), predicated on engagement and iteration with all stakeholders. We emphasize usability and technical concerns and describe the interdependency of technical and human considerations for mHealth systems in rural communities.
Topics: Biomedical Research; Cell Phone; Humans; Mobile Applications; Neglected Diseases; Software; Tropical Medicine
PubMed: 30383809
DOI: 10.1371/journal.pntd.0006791 -
PloS One 2019Delivery of preventive chemotherapy (PC) through mass drug administration (MDA) is used to control or eliminate five of the most common neglected tropical diseases... (Review)
Review
BACKGROUND
Delivery of preventive chemotherapy (PC) through mass drug administration (MDA) is used to control or eliminate five of the most common neglected tropical diseases (NTDs). The success of an MDA campaign relies on the ability of drug distributors and their supervisors-the NTD front-line workers-to reach populations at risk of NTDs. In the past, our understanding of the demographics of these workers has been limited, but with increased access to sex-disaggregated data, we begin to explore the implications of gender and sex for the success of NTD front-line workers.
METHODOLOGY/PRINCIPAL FINDINGS
We reviewed data collected by USAID-supported NTD projects from national NTD programs from fiscal years (FY) 2012-2017 to assess availability of sex-disaggregated data on the workforce. What we found was sex-disaggregated data on 2,984,908 trainees trained with financial support from the project. We then analyzed the percentage of males and females trained by job category, country, and fiscal year. During FY12, 59% of these data were disaggregated by sex, which increased to nearly 100% by FY15 and was sustained through FY17. In FY17, 43% of trainees were female, with just four countries reporting more females than males trained as drug distributors and three countries reporting more females than males trained as trainers/supervisors. Except for two countries, there were no clear trends over time in changes to the percent of females trained.
CONCLUSIONS/SIGNIFICANCE
There has been a rapid increase in availability of sex-disaggregated data, but little increase in recruitment of female workers in countries included in this study. Women continue to be under-represented in the NTD workforce, and while there are often valid reasons for this distribution, we need to test this norm and better understand gender dynamics within NTD programs to increase equity.
Topics: Chemoprevention; Female; Global Health; Humans; Male; Mass Drug Administration; Neglected Diseases; Sex Factors; Sexism; Tropical Medicine
PubMed: 31856174
DOI: 10.1371/journal.pone.0224925 -
PLoS Neglected Tropical Diseases May 2021The second World Neglected Tropical Diseases (NTDs) Day was celebrated on 30 January 2021. To mark the occasion, the World Health Organization (WHO) launched its roadmap...
The second World Neglected Tropical Diseases (NTDs) Day was celebrated on 30 January 2021. To mark the occasion, the World Health Organization (WHO) launched its roadmap for NTDs for the period 2021 to 2030, which is aimed at increasing prevention and control of these too-long neglected diseases. Described here is a global overview on past achievements, current challenges, and future prospects for the WHO NTDs roadmap 2021-2030.
Topics: Communicable Disease Control; Global Health; Humans; Neglected Diseases; Tropical Medicine; World Health Organization
PubMed: 33983940
DOI: 10.1371/journal.pntd.0009373 -
The American Journal of Tropical... Oct 2021Compassion-the awareness of suffering coupled with the desire to relieve that suffering-is an evolved human capacity that offers significant benefits for individuals and...
Compassion-the awareness of suffering coupled with the desire to relieve that suffering-is an evolved human capacity that offers significant benefits for individuals and organizations. While the relief of suffering is central to tropical medicine and global health, compassion is more often assumed than explicit. Global health leaders participating in a compassionate leadership program recently reported that the most common personal barriers to compassionate leadership include inability to regulate workload, perfectionism, and lack of self-compassion; while the most common external challenges include excessive work-related demands, the legacy of colonialism, and the lack of knowledge on how to lead with compassion. These barriers can be surmounted. Within organizations, leaders are the primary shapers of compassionate cultures. Now is the time to bring our core compassionate values to bear in addressing the "unfinished business" of ensuring global health equity and deconstructing colonialist structures in global health and tropical medicine. Compassionate leadership offers us tools to complete this unfinished business.
Topics: Empathy; Global Health; Humans; Leadership; Tropical Medicine
PubMed: 34634766
DOI: 10.4269/ajtmh.21-0832 -
Proceedings of the Royal Society of... Jul 1947
Topics: Dermatitis; Humans; Lichen Planus; Lichenoid Eruptions; Lichens; Tropical Medicine
PubMed: 19993604
DOI: No ID Found -
Nature Jul 2018Infectious tropical diseases have a huge effect in terms of mortality and morbidity, and impose a heavy economic burden on affected countries. These diseases... (Review)
Review
Infectious tropical diseases have a huge effect in terms of mortality and morbidity, and impose a heavy economic burden on affected countries. These diseases predominantly affect the world's poorest people. Currently available drugs are inadequate for the majority of these diseases, and there is an urgent need for new treatments. This Review discusses some of the challenges involved in developing new drugs to treat these diseases and highlights recent progress. While there have been notable successes, there is still a long way to go.
Topics: Animals; Coinfection; Drug Discovery; Humans; Infections; Tropical Climate; Tropical Medicine
PubMed: 30046073
DOI: 10.1038/s41586-018-0327-4